Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids
Objectives: To evaluate the hematological profile, oxidative stress, and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids for 12 months. Design and methods: Twenty-one β-thalassemia/Hb E patients were given 2 capsules of 250 mg each of curcuminoids (a total of 500 mg)...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=76749103354&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/50591 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
id |
th-cmuir.6653943832-50591 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-505912018-09-04T04:42:42Z Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids Ruchaneekorn W. Kalpravidh Noppadol Siritanaratkul Praphaipit Insain Ratiya Charoensakdi Narumol Panichkul Suneerat Hatairaktham Somdet Srichairatanakool Chada Phisalaphong Eliezer Rachmilewitz Suthat Fucharoen Biochemistry, Genetics and Molecular Biology Objectives: To evaluate the hematological profile, oxidative stress, and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids for 12 months. Design and methods: Twenty-one β-thalassemia/Hb E patients were given 2 capsules of 250 mg each of curcuminoids (a total of 500 mg) daily for 12 months. Blood was collected every 2 months during treatment and 3 months after withdrawal and was determined for complete blood count, malonyldialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), reduced glutathione (GSH) in red blood cells (RBC), and non-transferrin bound iron (NTBI) in serum. Results: The increased oxidative stress in β-thalassemia/Hb E patients was shown by higher levels of MDA, SOD, GSH-Px in RBC, serum NTBI, and lower level of RBC GSH. Curcuminoids administration resulted in improvement of all the measured parameters as long as they were administered. After 3 months withdrawal of treatment, all parameters returned close to baseline levels. Conclusion: Curcuminoids may be used to ameliorate oxidative damage in patients with β-thalassemia/Hb E disease. © 2009 The Canadian Society of Clinical Chemists. 2018-09-04T04:42:42Z 2018-09-04T04:42:42Z 2010-03-01 Journal 00099120 2-s2.0-76749103354 10.1016/j.clinbiochem.2009.10.057 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=76749103354&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/50591 |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
topic |
Biochemistry, Genetics and Molecular Biology |
spellingShingle |
Biochemistry, Genetics and Molecular Biology Ruchaneekorn W. Kalpravidh Noppadol Siritanaratkul Praphaipit Insain Ratiya Charoensakdi Narumol Panichkul Suneerat Hatairaktham Somdet Srichairatanakool Chada Phisalaphong Eliezer Rachmilewitz Suthat Fucharoen Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids |
description |
Objectives: To evaluate the hematological profile, oxidative stress, and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids for 12 months. Design and methods: Twenty-one β-thalassemia/Hb E patients were given 2 capsules of 250 mg each of curcuminoids (a total of 500 mg) daily for 12 months. Blood was collected every 2 months during treatment and 3 months after withdrawal and was determined for complete blood count, malonyldialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), reduced glutathione (GSH) in red blood cells (RBC), and non-transferrin bound iron (NTBI) in serum. Results: The increased oxidative stress in β-thalassemia/Hb E patients was shown by higher levels of MDA, SOD, GSH-Px in RBC, serum NTBI, and lower level of RBC GSH. Curcuminoids administration resulted in improvement of all the measured parameters as long as they were administered. After 3 months withdrawal of treatment, all parameters returned close to baseline levels. Conclusion: Curcuminoids may be used to ameliorate oxidative damage in patients with β-thalassemia/Hb E disease. © 2009 The Canadian Society of Clinical Chemists. |
format |
Journal |
author |
Ruchaneekorn W. Kalpravidh Noppadol Siritanaratkul Praphaipit Insain Ratiya Charoensakdi Narumol Panichkul Suneerat Hatairaktham Somdet Srichairatanakool Chada Phisalaphong Eliezer Rachmilewitz Suthat Fucharoen |
author_facet |
Ruchaneekorn W. Kalpravidh Noppadol Siritanaratkul Praphaipit Insain Ratiya Charoensakdi Narumol Panichkul Suneerat Hatairaktham Somdet Srichairatanakool Chada Phisalaphong Eliezer Rachmilewitz Suthat Fucharoen |
author_sort |
Ruchaneekorn W. Kalpravidh |
title |
Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids |
title_short |
Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids |
title_full |
Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids |
title_fullStr |
Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids |
title_full_unstemmed |
Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids |
title_sort |
improvement in oxidative stress and antioxidant parameters in β-thalassemia/hb e patients treated with curcuminoids |
publishDate |
2018 |
url |
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=76749103354&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/50591 |
_version_ |
1681423617355677696 |